These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33885225)

  • 21. Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products.
    Zhang LL; Zhang DJ; Shi JX; Huang MY; Yu JM; Chen XJ; Wei X; Zou L; Lu JJ
    Phytomedicine; 2024 Sep; 132():155828. PubMed ID: 38905847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cobalt(III) prodrug-based nanomedicine for inducing immunogenic cell death and enhancing chemo-immunotherapy.
    Shang K; Montesdeoca N; Zhang H; Efanova E; Liang G; Ochs J; Karges J; Song H; Zhang L
    J Control Release; 2024 Sep; 373():493-506. PubMed ID: 39033985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoparticle-mediated immunogenic cell death for cancer immunotherapy.
    Qi H; Li Y; Geng Y; Wan X; Cai X
    Int J Pharm; 2024 May; 656():124045. PubMed ID: 38561134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy.
    Sansone C; Bruno A; Piscitelli C; Baci D; Fontana A; Brunet C; Noonan DM; Albini A
    Cells; 2021 Jan; 10(2):. PubMed ID: 33504012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photothermal MnO
    Chen Z; Zhang Q; Huang Q; Liu Z; Zeng L; Zhang L; Chen X; Song H; Zhang J
    Int J Pharm; 2022 Apr; 617():121578. PubMed ID: 35176333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomaterials That Induce Immunogenic Cell Death.
    Li D; Liu S; Ma Y; Liu S; Liu Y; Ding J
    Small Methods; 2023 May; 7(5):e2300204. PubMed ID: 37116170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitric Oxide Induces Immunogenic Cell Death and Potentiates Cancer Immunotherapy.
    Jiang W; Dong W; Li M; Guo Z; Wang Q; Liu Y; Bi Y; Zhou H; Wang Y
    ACS Nano; 2022 Mar; 16(3):3881-3894. PubMed ID: 35238549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future.
    Sen S; Won M; Levine MS; Noh Y; Sedgwick AC; Kim JS; Sessler JL; Arambula JF
    Chem Soc Rev; 2022 Feb; 51(4):1212-1233. PubMed ID: 35099487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineering immunogenic cell death with nanosized drug delivery systems improving cancer immunotherapy.
    Yan W; Lang T; Qi X; Li Y
    Curr Opin Biotechnol; 2020 Dec; 66():36-43. PubMed ID: 32673944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eliciting Immunogenic Cell Death via a Unitized Nanoinducer.
    Dai Z; Tang J; Gu Z; Wang Y; Yang Y; Yang Y; Yu C
    Nano Lett; 2020 Sep; 20(9):6246-6254. PubMed ID: 32786942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trial watch: chemotherapy-induced immunogenic cell death in oncology.
    Sprooten J; Laureano RS; Vanmeerbeek I; Govaerts J; Naulaerts S; Borras DM; Kinget L; Fucíková J; Špíšek R; Jelínková LP; Kepp O; Kroemer G; Krysko DV; Coosemans A; Vaes RDW; De Ruysscher D; De Vleeschouwer S; Wauters E; Smits E; Tejpar S; Beuselinck B; Hatse S; Wildiers H; Clement PM; Vandenabeele P; Zitvogel L; Garg AD
    Oncoimmunology; 2023; 12(1):2219591. PubMed ID: 37284695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation-Induced Immunogenic Cell Death for Cancer Radioimmunotherapy.
    Liu T; Pei P; Shen W; Hu L; Yang K
    Small Methods; 2023 May; 7(5):e2201401. PubMed ID: 36811166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nano Delivery of Chemotherapeutic ICD Inducers for Tumor Immunotherapy.
    Guo J; Zou Y; Huang L
    Small Methods; 2023 May; 7(5):e2201307. PubMed ID: 36604976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenic cell death-based cancer vaccines: promising prospect in cancer therapy.
    Wang J; Ma J; Xie F; Miao F; Lv L; Huang Y; Zhang X; Yu J; Tai Z; Zhu Q; Bao L
    Front Immunol; 2024; 15():1389173. PubMed ID: 38745666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunogenic cell death in hematological malignancies].
    Matsushita M
    Rinsho Ketsueki; 2021; 62(7):709-716. PubMed ID: 34349052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local Drug Delivery Techniques for Triggering Immunogenic Cell Death.
    Ren E; Wang Y; Liang T; Zheng H; Shi J; Cheng Z; Li H; Gu Z
    Small Methods; 2023 Sep; 7(9):e2300347. PubMed ID: 37259275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenic cell death in cancer immunotherapy.
    Choi M; Shin J; Lee CE; Chung JY; Kim M; Yan X; Yang WH; Cha JH
    BMB Rep; 2023 May; 56(5):275-286. PubMed ID: 37081756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomimetic Active Materials Guided Immunogenic Cell Death for Enhanced Cancer Immunotherapy.
    Huang G; Liu L; Pan H; Cai L
    Small Methods; 2023 May; 7(5):e2201412. PubMed ID: 36572642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy.
    Demuynck R; Engelen Y; Skirtach AG; De Smedt SC; Lentacker I; Krysko DV
    Trends Cancer; 2024 Jun; 10(6):486-489. PubMed ID: 38553361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polypeptide-Based K
    Lee D; Ha J; Ahn H; Jeong SD; Jeong M; Park JH; Yun CO; Kim YC
    ACS Appl Bio Mater; 2021 Dec; 4(12):8333-8342. PubMed ID: 35005917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.